EP1637126A2 — Methods for treating inflammation of the eye
Assigned to Allergan Inc · Expires 2006-03-22 · 20y expired
What this patent protects
Methods for treating inflammation-mediated conditions of the eye are described comprising implanting into the vitreous of the eye of an individual a bio-erodible implant comprising a steroidal anti-inflammatory agent and a bio-erodible polymer.
USPTO Abstract
Methods for treating inflammation-mediated conditions of the eye are described comprising implanting into the vitreous of the eye of an individual a bio-erodible implant comprising a steroidal anti-inflammatory agent and a bio-erodible polymer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.